Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1: Patients who meet the Western medical diagnostic criteria outlined in the Chinese protocol of diagnosis and treatment of colorectal cancer(2020 edition), have undergone laparoscopic curative surgery, and were preoperatively staged as high-risk Stage II or Stage III on CT 2: Aged 18–75, regardless of gender 3: KPS > 60 points, with an expected survival period of >6 months 4: Have not recently taken antibiotics, hormones, probiotics, gastrointestinal motility agents, traditional Chinese medicine, or other medications that affect the intestinal microbiota 5: Demonstrate good compliance and are able to tolerate drug therapy 6: Are able to cooperate with this study and provide timely feedback on medication use and treatment status 7: Voluntarily participate in this study and sign an informed consent form
Exclusion criteria
Exclusion criteria: 1: Patients with severe underlying diseases of the cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems 2: Patients with a history of or concurrent malignant tumors 3: Patients with drug allergies 4: Patients with cognitive or psychiatric disorders 5: Patients who intend to become pregnant in the near future, are currently pregnant, or are breastfeeding 6: Patients currently participating in other clinical drug trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery time for bowel sounds;Time of first postoperative exhaust and defecation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gastrointestinal Symptom Rating Scale;Fatigue Scale;Oxygen Radical Detection;Rehabilitation Scale;Inflammatory factors;Gastrointestinal hormones; | — |
Countries
China
Contacts
Guangdong Hospital of Traditional Chinese Medicine